Zhu Jie, Luo He-sheng, Chen Ling, Liang Cheng-bo, Xia Hong
Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Zhonghua Yi Xue Za Zhi. 2011 Mar 29;91(12):840-4.
To investigate the effects and mechanism of cholecystokinin octapeptide (CCK-8S) on the contractile activity of smooth muscles, L-type calcium current and membrane potentials of proximal colon myocytes in guinea pig.
(1) Strips of proximal colon were obtained from adult guinea pigs. The contraction of these stripes was measured by a RM6240 multi-channel physiological signal system. (2) Suspension of single smooth muscle cells (SMCs) were obtained from proximal colon and isolated by enzymatic digestion. The effect of CCK-8S on intracellular calcium concentration ([Ca(2+)]i) of SMCs was examined by fura-2-loaded microfluorimetric measurement. (3) Resting potential (RP), action potential (AP) and L-type calcium current (I(Ca-L)) were recorded by patch-clamp technique.
(1) The contractile amplitude and frequency of muscle stripes enhanced by CCK-8S (10(-7) mol/L) were (149 ± 12)% and (132 ± 13)% respectively of those of control group (all P < 0.05). They were significantly attenuated by pretreating strips with CCK1 receptor antagonist devazepide (10(-7) mol/L), L-type calcium channel blocker nifedipine (10(-5) mol/L), Ca(2+)-ATPase inhibitor TG (thapsigargin) (10(-5) mol/L) and BA (boric acid) (10(-5) mol/L) respectively. (2) [Ca(2+)]i of SMCs intensified by CCK-8S was (738 ± 24)% of that of control group. And it was inhibited by pretreating SMCs with devazepide (all P < 0.05). (3) After the superfusion of CCK-8S, RP depolarized to (52 ± 9)%, the exogenously stimulated peak values of AP rose to (140 ± 4)% and fast repolarization time of AP decreased to (61 ± 13)% (all P < 0.05). They were significantly inhibited when these cells were pretreated with devazepide and/or nifedipine (n = 8, P < 0.05 for each group) whereas CI 988 had little effect. (4) The CCK-8S-evoked I(Ca-L) of SMCs at the voltage of + 10 mV was boosted to (138 ± 7)%. Such an effect was suppressed by a pretreatment with nifedipine, devazepide, TG and BA respectively. In the presence of an inhibitor of inositol 1,4,5-trisphosphate (IP3) receptors, heparin (10(-6) mol/L) and an protein kinase C (PKC) inhibitor, saurosporine (10(-6) mol/L), CCK-8S did not significantly intensify I(Ca-L) (all P > 0.05).
CCK-8S promotes proximal colon contraction by CCK1 receptors through the activation of IP3-mediated PKC pathway.
探讨八肽胆囊收缩素(CCK-8S)对豚鼠近端结肠平滑肌收缩活动、L型钙电流及细胞膜电位的影响及其机制。
(1)取成年豚鼠近端结肠条,用RM6240多通道生理信号系统测定其收缩情况。(2)采用酶消化法分离获得近端结肠单个平滑肌细胞(SMC)悬液,用fura-2负载微荧光测定法检测CCK-8S对SMC细胞内钙浓度([Ca(2+)]i)的影响。(3)采用膜片钳技术记录静息电位(RP)、动作电位(AP)和L型钙电流(I(Ca-L))。
(1)CCK-8S(10(-7)mol/L)使肌条收缩幅度和频率分别增强至对照组的(149±12)%和(132±13)%(均P<0.05)。用CCK1受体拮抗剂地伐西匹(10(-7)mol/L)、L型钙通道阻滞剂硝苯地平(10(-5)mol/L)、Ca(2+)-ATP酶抑制剂TG(毒胡萝卜素)(10(-5)mol/L)和BA(硼酸)(10(-5)mol/L)预处理肌条后,收缩幅度和频率均显著减弱。(2)CCK-8S使SMC的[Ca(2+)]i增强至对照组的(738±24)%。用地伐西匹预处理SMC可抑制此作用(均P<0.05)。(3)灌注CCK-8S后,RP去极化至(52±9)%,外源性刺激的AP峰值升至(140±4)%,AP快速复极化时间降至(61±13)%(均P<0.05)。用地伐西匹和/或硝苯地平预处理这些细胞后,上述变化均显著受抑制(n=8,每组P<0.05),而CI 988作用甚微。(4)CCK-8S使SMC在+10mV电压下诱发的I(Ca-L)增强至(138±7)%。分别用硝苯地平、地伐西匹、TG和BA预处理可抑制此作用。在存在肌醇1,4,5-三磷酸(IP3)受体抑制剂肝素(10(-6)mol/L)和蛋白激酶C(PKC)抑制剂蛇孢菌素(10(-6)mol/L)时,CCK-8S未显著增强I(Ca-L)(均P>0.05)。
CCK-8S通过CCK1受体激活IP3介导的PKC途径促进近端结肠收缩。